DRTS

Alpha Tau Medical Ltd

14.40

Nov 11 • 7:24 AM ET +0.70 (5.11%)

Healthcare Biotechnology Israel Small NASD

Peers: NBTX TLX ATNM BCAX CGON RADX LNTH ARAY NVS ICCM

| Held by: IEFA SCZ IZRL EIS IXUS GWX ONEQ EHLS IDEV AVSD

Scroll to Statements

Index	-
Market Cap	1.33B
Enterprise Value	1.24B
Income	-92.57M
Sales	0.00M
Book/sh	0.48
Cash/sh	1.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	112
IPO	Mar 08, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	30.18
P/C	12.71
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	11.09
Current Ratio	11.09
Debt/Eq	0.34
LT Debt/Eq	0.31
Option/Short	Yes / Yes

EPS (ttm)	-1.04
EPS next Y	-0.54
EPS next Q	-0.15
EPS this Y	-82.12%
EPS next Y	44.10%
EPS next 5Y	4.92%
EPS past 3/5Y	0.15% -19.21%
Sales past 3/5Y	- -
EPS Y/Y TTM	-115.15%
Sales Y/Y TTM	-
EPS Q/Q	-301.43%
Sales Q/Q	-
Earnings	Aug 10 AMC
EPS/Sales Surpr.	-256.14% -98.27%

Insider Own	19.81%
Insider Trans	-0.72%
Inst Own	9.30%
Inst Trans	12.85%
ROA	-75.51%
ROE	-141.68%
ROIC	-159.91%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	8.12%
SMA50	2.01%
SMA200	32.56%
Trades

Shs Outstand	92.33M
Shs Float	74.16M
Short Float	5.29%
Short Ratio	7.24
Short Interest	3.92M
52W High	15.79 -8.80%
52W Low	3.43 319.83%
Volatility	5.48% 5.08%
ATR (14)	0.68
RSI (14)	56.57
Beta	1.28
Rel Volume	0.50
Avg Volume	541.33K
Volume	13,569

Perf Week	2.64%
Perf Month	4.80%
Perf Quarter	-0.69%
Perf Half Y	49.38%
Perf YTD	190.91%
Perf Year	265.48%
Perf 3Y	364.52%
Perf 5Y	45.16%
Perf 10Y	-
Recom	1.20
Target Price	20.60
Prev Close	13.70
Price	14.40
Change %	5.11%

Consensus

Strong Buy

Avg. Price Target

$20.60

Implied Upside

+43.1%

Analysts5incl. previous ratings

Rating Distribution4 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
May 28, 2026	Initiated	BBarclays	Overweight	$15	+4.2%
Mar 04, 2026	Downgrade	PPiper Sandler	Overweight → Neutral	$5	-65.3%
Dec 15, 2023	Initiated	CCitigroup	Buy	$8	-44.4%
Apr 24, 2023	Initiated	HH.C. Wainwright	Buy	$9	-37.5%
Apr 14, 2022	Initiated	CCantor Fitzgerald	Overweight	$20	+38.9%
Apr 08, 2022	Initiated	PPiper Sandler	Overweight	$19	+31.9%
Apr 04, 2022	Initiated	CCitigroup	Buy	$21	+45.8%

Oct-19-26 09:39AM	FDA Greenlights Expansion of Alpha Tau's Brain Cancer Trial, With New Data Weeks Away (NASDAQ: DRTS) (FinanceWire)
Sep-15-26 08:30AM	Alpha Tau's Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next. (FinanceWire)
Jul-29-26 09:06AM	Alpha Tau's Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda's Historical Benchmark (FinanceWire)
Jun-24-26 11:01AM	Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S. (FinanceWire)
Jun-03-26 10:52AM	DRTS Stock Shot Up A Whopping 22% Today Why A $196.5M Prostate Cancer Deal Got Investors Buzzing (Stocktwits) +18.48%
05:50AM	Loading…
Mar-11-26 05:50AM	Alpha Tau price target raised to $9 from $7 at Citi (TipRanks)
Feb-25-26 10:30AM	Alpha Tau price target raised to $12 from $9 at H.C. Wainwright (TipRanks) +13.86%
Jan-27-26 04:02AM	New Strong Sell Stocks for January 27th (Zacks)
Jan-23-26 02:50PM	DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event (ACCESSWIRE)
Jan-20-26 09:12AM	New Strong Sell Stocks for January 20th (Zacks) -9.27%
Dec-09-25 12:48PM	Sidoti Events, LLC's Year-End Virtual Investor Conference (ACCESSWIRE) +8.74%
Aug-11-25 04:02PM	Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) +5.01% -8.71%
May-28-25 08:30AM	Alpha Tau to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
May-19-25 04:01PM	Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) +11.11% +5.16%
May-12-25 04:01PM	Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors (GlobeNewswire) -5.08%
08:30AM	Loading…
May-06-25 08:30AM	Alpha Tau to Participate in May Investor Conferences (GlobeNewswire)
Apr-28-25 09:00AM	Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical (PR Newswire)
09:00AM	Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals (GlobeNewswire)
Apr-02-25 08:30AM	Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma (GlobeNewswire)
Mar-18-25 03:30PM	Q1 Virtual Investor Summit: On-Demand Presentations Now Live (ACCESS Newswire)
09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Mar-12-25 04:02PM	Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-27-25 09:00AM	Alpha Tau to Participate in March Investor Conferences (GlobeNewswire)
Feb-24-25 08:30AM	Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification (GlobeNewswire)
Feb-03-25 08:30AM	Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease (GlobeNewswire)
Jan-27-25 09:00AM	Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day (GlobeNewswire)
Dec-18-24 08:30AM	Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company RandD Update Day (GlobeNewswire)
08:30AM	Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day (GlobeNewswire)
Dec-17-24 09:00AM	Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor (GlobeNewswire)
Dec-11-24 08:30AM	Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
08:30AM	Loading…
Dec-06-24 08:30AM	Alpha Tau to Participate in Ladenburgs Oncology Innovators & Investors Symposium (GlobeNewswire)
08:30AM	Alpha Tau to Participate in Ladenburg's Oncology Innovators and Investors Symposium (GlobeNewswire)
Nov-19-24 04:00PM	Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-13-24 08:30AM	Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference (GlobeNewswire)
Oct-21-24 08:30AM	Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme (GlobeNewswire)
Oct-11-24 08:57AM	Alpha Taus Alpha DaRT Advances Lung Cancer Treatment (TipRanks)
Oct-10-24 08:30AM	Alpha Tau Treats First Patient with Recurrent Lung Cancer (GlobeNewswire)
Sep-20-24 08:30AM	Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC (GlobeNewswire)
Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Aug-22-24 08:30AM	Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference (GlobeNewswire)
Aug-14-24 04:02PM	Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +6.64%
Jun-25-24 08:30AM	Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers (GlobeNewswire)
May-21-24 08:45AM	Alpha Tau to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-24 09:53PM	DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024 (InvestorPlace)
04:01PM	Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-13-24 08:30AM	Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer (GlobeNewswire)
May-06-24 08:30AM	Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow (GlobeNewswire)
May-01-24 08:30AM	Alpha Tau to Participate in May Investor Conferences (GlobeNewswire)
Mar-25-24 08:50AM	Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit (GlobeNewswire)
Mar-07-24 10:53PM	DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023 (InvestorPlace)
04:01PM	Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-26-24 08:30AM	Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference (GlobeNewswire) -6.05%
Jan-22-24 09:40AM	Is Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-20-23 09:15AM	Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-05-23 10:25AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE)
Nov-29-23 08:30AM	Alpha Tau to Participate in Sidoti Small-Cap Conference (GlobeNewswire)
Nov-28-23 08:30AM	Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer (GlobeNewswire)
Nov-20-23 08:30AM	Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer (GlobeNewswire)
Nov-16-23 04:30PM	Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-01-23 08:30AM	Alpha Tau to Participate in November Investor Conferences (GlobeNewswire)
07:00AM	Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now (GlobeNewswire)
Oct-31-23 07:00AM	Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now (GlobeNewswire) +7.45%
Oct-30-23 08:30AM	Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility (GlobeNewswire)
Oct-24-23 09:00AM	Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board (GlobeNewswire) +5.11%
Oct-04-23 07:00AM	Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now (GlobeNewswire)
Oct-03-23 07:00AM	Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now (GlobeNewswire)
Sep-14-23 08:30AM	Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israels Hadassah Medical Center (GlobeNewswire)
Aug-28-23 04:02PM	Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-24-23 08:00AM	Alpha Tau Medical to Participate in September Investor Conferences (GlobeNewswire)
Aug-17-23 05:00PM	Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT (GlobeNewswire)
Aug-08-23 07:00AM	Presenting on the Emerging Growth Conference on August 9 & 10 Register Now (GlobeNewswire)
Aug-06-23 08:28AM	Insiders own 24% of Alpha Tau Medical Ltd. (NASDAQ:DRTS) shares but individual investors control 54% of the company (Simply Wall St.)
Aug-02-23 09:00AM	Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023 (GlobeNewswire)
Jun-13-23 08:00AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-24-23 04:01PM	Alpha Tau Medical to Participate in June Investor Conferences (GlobeNewswire)
May-23-23 04:01PM	Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire) -6.78%
May-17-23 04:30PM	Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University (GlobeNewswire)
May-11-23 04:00PM	Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open (GlobeNewswire) +7.89%
May-03-23 04:00PM	Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day (GlobeNewswire)
Apr-03-23 09:10AM	Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial (GlobeNewswire)
Mar-29-23 04:00PM	Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit (GlobeNewswire) +5.30%
Mar-12-23 08:30AM	Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank (GlobeNewswire)
Mar-09-23 04:10PM	Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-08-23 05:00PM	Alpha Tau Announces Alpha DaRT Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial (GlobeNewswire) -8.64%
Mar-03-23 08:30AM	Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem Headquarters (GlobeNewswire)
Mar-01-23 08:30AM	Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases (GlobeNewswire) +7.28%
Feb-21-23 04:00PM	Alpha Tau to Participate in Citis 2023 Healthcare Services, Medtech, Tools & HCIT Conference (GlobeNewswire) -6.07%
Dec-13-22 08:00AM	Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023 (GlobeNewswire)
Nov-22-22 04:02PM	Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -7.86%
Nov-09-22 08:00AM	Alpha Tau to Present at Upcoming November Investor Conferences (GlobeNewswire) -5.66%
Oct-21-22 04:01PM	Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology (GlobeNewswire) +5.78%
Sep-08-22 04:05PM	Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the Alpha DaRT Treatment and Standard-of-Care Immunotherapy, Chemotherapy and Anti-Angiogenic Therapy (GlobeNewswire)
Sep-01-22 04:15PM	Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer (GlobeNewswire) -9.85%
Aug-30-22 04:05PM	Alpha Tau Medical to Participate in Upcoming September Investor Conferences (GlobeNewswire) -17.14%
Aug-25-22 04:05PM	Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -5.23%
Aug-22-22 09:00AM	Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning (GlobeNewswire) -5.30%
Jul-05-22 04:01PM	Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials (GlobeNewswire) +38.71%
Jun-22-22 04:01PM	Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT (PR Newswire) +5.02%
Jun-16-22 04:01PM	Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site (PR Newswire) +25.35% -8.06%
Jun-08-22 09:10AM	Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT in Recurrent Cutaneous SCC (PR Newswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Levy Raphi	Chief Financial Officer	Aug 21 '26	Option Exercise	2.98	2,871	8,556	93,051	Aug 25 10:34 AM
Levy Raphi	Chief Financial Officer	Aug 21 '26	Sale	15.00	2,871	43,073	90,180	Aug 25 10:34 AM
Raphael (Raphi) Aryeh Levy	Officer	Aug 21 '26	Proposed Sale	14.36	5,000	71,800		Aug 21 05:00 PM
Levy Raphi	Chief Financial Officer	Aug 11 '26	Option Exercise	2.98	17,730	52,835	107,910	Aug 12 12:18 PM
Levy Raphi	Chief Financial Officer	Aug 11 '26	Sale	14.00	17,730	248,277	90,180	Aug 12 12:18 PM
Levy Raphi	Chief Financial Officer	Jul 06 '26	Option Exercise	2.98	2,270	6,765	92,450	Jul 07 07:49 AM
Levy Raphi	Chief Financial Officer	Jul 06 '26	Sale	14.00	2,270	31,782	90,180	Jul 07 07:49 AM
Levy Raphi	Officer	Jul 06 '26	Proposed Sale	13.23	20,000	264,600		Jul 06 11:55 AM
Levy Raphi	Chief Financial Officer	Jul 02 '26	Option Exercise	2.98	17,873	53,262	108,053	Jul 06 11:37 AM
Levy Raphi	Chief Financial Officer	Jul 02 '26	Sale	13.00	17,873	232,397	90,180	Jul 06 11:37 AM
Levy Raphi	Chief Financial Officer	Jul 01 '26	Option Exercise	2.98	2,127	6,338	92,307	Jul 02 11:45 AM
Levy Raphi	Chief Financial Officer	Jul 01 '26	Sale	13.02	2,127	27,691	90,180	Jul 02 11:45 AM
Levy Raphi	Officer	Jul 01 '26	Proposed Sale	12.58	20,000	251,600		Jul 02 06:32 AM
Levy Raphi	Chief Financial Officer	Jun 30 '26	Sale	12.00	20,000	240,044	90,180	Jul 01 08:21 AM
Levy Raphi	Officer	Jun 30 '26	Proposed Sale	11.22	20,000	224,400		Jun 30 11:34 AM
Levy Raphi	Chief Financial Officer	Jun 25 '26	Sale	11.00	20,000	220,004	110,180	Jun 26 08:17 AM
Levy Raphi	Officer	Jun 25 '26	Proposed Sale	10.05	20,000	201,000		Jun 26 06:45 AM
Levy Raphi	Chief Financial Officer	Jun 23 '26	Sale	9.55	17,500	167,051	130,180	Jun 25 10:16 AM
Levy Raphi	Officer	Jun 23 '26	Proposed Sale	10.03	17,500	175,525		Jun 23 06:12 AM
Levy Raphi	Chief Financial Officer	Jun 03 '26	Sale	10.83	32,500	352,115	147,680	Jun 04 02:29 PM
Levy Raphi	Officer	Jun 03 '26	Proposed Sale	8.93	32,500	290,225		Jun 04 07:28 AM
Levy Raphi	Officer	Feb 25 '26	Proposed Sale	7.39	10,000	73,950		Feb 26 07:28 AM
Gat Amnon	Officer	Feb 02 '26	Proposed Sale	6.94	87,010	603,849		Feb 02 08:27 AM
Levy Raphi	Officer	Jan 13 '26	Proposed Sale	7.09	15,000	106,350		Jan 14 07:52 AM
Levy Raphi	Officer	Jan 09 '26	Proposed Sale	6.41	25,000	160,250		Jan 12 07:35 AM
Gat Amnon	Officer	Jan 08 '26	Proposed Sale	5.90	61,745	364,296		Jan 09 06:34 AM
Levy Raphi	Officer	Jan 08 '26	Proposed Sale	5.90	20,000	118,000		Jan 09 06:06 AM
Gat Amnon	Officer	Dec 10 '25	Proposed Sale	4.23	60,092	254,189		Dec 11 07:03 AM
Gat Amnon	Officer	Dec 01 '25	Proposed Sale	3.97	16,000	63,520		Dec 01 06:48 AM

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

CEO & ChairmanMr. Uzi Sofer

Chief Financial OfficerMr. Raphi Levy

Chief Operations OfficerMr. Amnon Gat

Chief Technology OfficerMr. Ronen Segal

Chief Medical Officer & Member of Scientific Advisory BoardDr. Robert B. Den M.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

DRTS

Alpha Tau Medical Ltd

Upgrade your Finviz experience

All the Features.
Half the Price.